29 results on '"Schönbeck Y"'
Search Results
2. The creation of the Global Scales for Early Development (GSED) for children aged 0-3 years: combining subject matter expert judgements with big data
- Author
-
McCray, G, McCoy, D, Kariger, P, Janus, M, Black, MM, Chang, SM, Tofail, F, Eekhout, Iris, Waldman, M, van Buuren, S, Khanam, R, Sazawal, S, Nizar, A, Schönbeck, Y, Zongo, A, Brentani, A, Zhang, Y, Dua, T, Cavallera, V, Raikes, A, Weber, AM, Bromley, K, Baqui, A, Dutta, A, Nisar, I, Detmar, SB, Anago, R, Mercadante, P, Jiang, F, Kaur, R, Hepworth, K, Rubio-Codina, M, Kembou, SN, Ahmed, S, Lancaster, GA, Gladstone, M, Leerstoel van Buuren, Methodology and statistics for the behavioural and social sciences, Leerstoel van Buuren, Methodology and statistics for the behavioural and social sciences, Epidemiology and Data Science, and APH - Methodology
- Subjects
Child health ,Health Policy ,Other study design ,Public Health, Environmental and Occupational Health ,Paediatrics - Abstract
IntroductionWith the ratification of the Sustainable Development Goals, there is an increased emphasis on early childhood development (ECD) and well-being. The WHO led Global Scales for Early Development (GSED) project aims to provide population and programmatic level measures of ECD for 0–3 years that are valid, reliable and have psychometrically stable performance across geographical, cultural and language contexts. This paper reports on the creation of two measures: (1) the GSED Short Form (GSED-SF)—a caregiver reported measure for population-evaluation—self-administered with no training required and (2) the GSED Long Form (GSED-LF)—a directly administered/observed measure for programmatic evaluation—administered by a trained professional.MethodsWe selected 807 psychometrically best-performing items using a Rasch measurement model from an ECD measurement databank which comprised 66 075 children assessed on 2211 items from 18 ECD measures in 32 countries. From 766 of these items, in-depth subject matter expert judgements were gathered to inform final item selection. Specifically collected were data on (1) conceptual matches between pairs of items originating from different measures, (2) developmental domain(s) measured by each item and (3) perceptions of feasibility of administration of each item in diverse contexts. Prototypes were finalised through a combination of psychometric performance evaluation and expert consensus to optimally identify items.ResultsWe created the GSED-SF (139 items) and GSED-LF (157 items) for tablet-based and paper-based assessments, with an optimal set of items that fit the Rasch model, met subject matter expert criteria, avoided conceptual overlap, covered multiple domains of child development and were feasible to implement across diverse settings.ConclusionsState-of-the-art quantitative and qualitative procedures were used to select of theoretically relevant and globally feasible items representing child development for children aged 0–3 years. GSED-SF and GSED-LF will be piloted and validated in children across diverse cultural, demographic, social and language contexts for global use.
- Published
- 2023
3. JGZ-richtlijn ondergewicht
- Author
-
Lanting, C.I., Wolff, M. de, Zoonen, R. van, and Schönbeck, Y.
- Subjects
Gewicht ,Life ,CH - Child Health ,Richtlijnen ,Ondervoeding ,Screening ,ELSS - Earth, Life and Social Sciences ,Jeugdgezondheidszorg ,Healthy for Life ,Healthy Living ,Ondergewicht - Abstract
Deze richtlijn is bedoeld voor JGZ-professionals (dit zijn jeugdartsen, verpleegkundig specialisten , 1 jeugdverpleegkundigen, doktersassistenten) en beoogt richtinggevend te zijn bij het handelen tijdens contacten met individuele 0-18 jarigen en hun ouders/verzorgers. De richtlijn ‘Ondergewicht’ beschrijft het normale gewichtsverloop en de begrippen ondergewicht en ondervoeding en geeft handelingsaanbevelingen ten behoeve van: 1. het monitoren van het gewicht en het signaleren van ondergewicht en ondervoeding; 2. het verwijzen bij ondergewicht en/of een afbuigende gewichtscurve; 3. de advisering bij ondergewicht.
- Published
- 2019
4. Prenatale Screening Infectieziekten en Erytrocytenimmunisatie (PSIE): Procesmonitor 2017
- Author
-
Ploeg, C.P.B. van der, Schönbeck, Y., Oomen, P., and Vos, K.
- Subjects
Life ,CH - Child Health ,Prenatale screening ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Erytrocytenimmunisatie ,Healthy Living ,Infectieziekten - Abstract
De Prenatale Screening Infectieziekten en Erytrocytenimmunisatie (PSIE) is een landelijk bevolkingsonderzoek waarbij een zwangere vrouw in het eerste verloskundige consult een bloedonderzoek aangeboden krijgt. Het bloed wordt gescreend op hepatitis B (hepB), syfilis, HIV, Rhesus (D)-antigeen (RhD), irregulaire erytrocyten antistoffen (IEA) en Rhesus (c)-antigeen (Rhc). Als uitslagen daartoe aanleiding geven, kunnen er binnen dit bevolkingsonderzoek verschillende acties in gang worden gezet. Het bevolkingsonderzoek heeft als doel hepatitis B- en HIV-dragerschap, congenitale syfilis en hemolytische ziekten van de foetus en/2017. Dit eerste onderzoek wordt bij voorkeur voor de 13e week van de zwangerschap gedaan. Vervolgstappen later in de zwangerschap zijn deels in 2018 uitgevoerd.
- Published
- 2019
5. Aangeboren afwijkingen in Nederland 2010-2016: gebaseerd op de Landelijke Perinatale Registraties
- Author
-
Grevinga, M., Schönbeck, Y., Hindori-Mohangoo, A.D., Reijnders, M.E.B., and Detmar, S.B.
- Subjects
Aangeboren afwijkingen ,Monitoring ,Life ,Health ,CH - Child Health ,Prevalentie ,Nederland ,Healthy for Life ,Healthy Living ,Pasgeborenen - Abstract
In opdracht van en gesubsidieerd door het Ministerie van Volksgezondheid, Welzijn en Sport is dit rapport over de prevalentie van aangeboren afwijkingen in Nederland over de periode 2010-2016 uitgebracht. Het is van belang om de prevalentie van de aangeboren afwijkingen te monitoren, omdat het ontstaan van aangeboren afwijkingen samenhangt met diverse biomedische, sociale en gedragsfactoren die deels te voorkomen zijn. Met een continue monitor zijn eventuele (onverwachte) stijgingen of dalingen (trends) in prevalentie tijdig te signaleren. Methode Perined beheert de landelijke perinatale registratie waarop een landelijke schatting van de prevalentie van aangeboren afwijkingen in Nederland gemaakt wordt. Deze landelijke perinatale registratie bestaat uit vier deelregistraties: LVR1, LVRh, LVR2 en LNR. In de Landelijke Verloskunde Registratie (LVR) worden door verloskundigen (LVR1), huisartsen (LVRh) en gynaecologen (LVR2) gegevens over zwangerschappen, baringen, pasgeborenen en kraambedden van zwangerschappen met een duur van tenminste 16 weken geregistreerd. Kinderartsen en neonatologen registreren alle opnames, overnames en heropnames van pasgeborenen die zijn opgenomen binnen 28 dagen na de geboorte in de Landelijke Neonatologie Registratie (LNR). In elk van de deelregistraties worden ook de aangeboren afwijkingen geregistreerd. Sinds 2010 koppelt PRN (in 2015 overgegaan in Perined) deze deelregistraties tot één landelijke LVR/LNR-bestand, dat vervolgens gebruikt wordt om de prevalentie van de aangeboren afwijkingen in Nederland te berekenen. Sinds 2014 wordt een nieuwe koppelingstechniek gebruikt, die beter in staat is dubbele cases uit het bestand te halen. Daarnaast is er vanaf 2014 voor gekozen om de WHO definitie te hanteren met als inclusiecriteria een zwangerschapsduur vanaf 22 voltooide weken en, indien de zwangerschapsduur onbekend is, een geboortegewicht vanaf 500 gram. Door deze wijzigingen is een trendbreuk ontstaan tussen 2013 en 2014. In dit rapport zijn de prevalenties sinds 2010 weergegeven. In verband met de methodologische wijzigingen in de onderliggende bestanden, focussen we op de stijgingen/dalingen in prevalentie over de jaren 2014-2016. Resultaten In de periode 2014-2016 werden jaarlijks ongeveer 5.000 pasgeborenen met aangeboren afwijkingen geregistreerd in Nederland. De prevalenties in deze jaren liepen uiteen van 3,1% (95% BI 3,08-3,10) in 2014, naar 3,0% (95% BI 3,00-3,03) in 2015 en 2,8% (95% BI 2,77-2,78) in 2016. In 2016 werden significant minder aangeboren afwijkingen geregistreerd dan in 2014 (p
- Published
- 2019
6. Evaluatie van de neonatale hielprikscreening bij kinderen geboren in 2016
- Author
-
Ploeg, C.P.B. van der, Olthof, M.C., Eekhout, I, Schönbeck, Y., and Verkerk, P.H.
- Subjects
Health ,Human Performances ,CH - Child Health ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Healthy Living - Published
- 2018
7. Procesmonitoring 2016: prenatale screening infectieziekten en erytrocytenimmunisatie (PSIE)
- Author
-
Ploeg, C.P.B. van der, Schönbeck, Y., Oomen, P., and Vos, K.
- Subjects
Life ,Health ,CH - Child Health ,Prenatale screening ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Erytrocytenimmunisatie ,Healthy Living ,Infectieziekten - Abstract
Deze monitor beschrijft de belangrijkste resultaten van het bevolkingsonderzoek PSIE voor 2016 in vergelijking met voorgaande jaren. De monitor omvat de gegevens van zwangeren met een eerste bloedonderzoek voor de PSIE in 2016. Dit eerste onderzoek wordt bij voorkeur voor de 13e week van de zwangerschap gedaan. Vervolgstappen later in de zwangerschap zijn deels in 2017 uitgevoerd. Alle zwangeren krijgen tijdens het eerste verloskundig consult een bloedonderzoek aangeboden: de Prenatale Screening op Infectieziekten en Erytrocytenimmunisatie (PSIE). Het bloed wordt gescreend op hepatitis B (hepB), syfilis, HIV, Rhesus (D)-antigeen (RhD), Rhesus (c)-antigeen (Rhc) en irregulaire erytrocyten antistoffen. Als de uitslagen daartoe aanleiding geven, kunnen er binnen dit bevolkingsonderzoek verschillende acties in gang worden gezet. Het bevolkingsonderzoek heeft als doel hepatitis B- en HIV-dragerschap, congenitale syfilis en hemolytische ziekten van de foetus en/of de pasgeborene te voorkomen.
- Published
- 2018
8. Evaluatie van de neonatale hielprikscreening bij kinderen geboren in 2015
- Author
-
Schönbeck, Y. and Verkerk, P.H.
- Subjects
Health ,Human Performances ,CH - Child Health ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Healthy Living - Published
- 2018
9. Procesmonitoring 2015: prenatale screening infectieziekten en erytrocytenimmunisatie (PSIE)
- Author
-
Ploeg, C.P.B. van der, Schönbeck, Y., Oomen, P., and Vos, K.
- Subjects
Life ,Health ,CH - Child Health ,Prenatale screening ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Erytrocytenimmunisatie ,Healthy Living ,Infectieziekten - Abstract
Deze monitor beschrijft de belangrijkste resultaten van het bevolkingsonderzoek PSIE voor 2015 in vergelijking met voorgaande jaren [1-5]. De monitor omvat de gegevens van zwangeren met een eerste bloedonderzoek voor de PSIE in 2015. Dit eerste onderzoek wordt bij voorkeur voor de 13e week van de zwangerschap gedaan. Vervolgstappen later in de zwangerschap zijn deels in 2016 uitgevoerd.
- Published
- 2017
10. Performance of a four-step newborn screening strategy for CF in the Dutch screening program: WS 10.4
- Author
-
Dankert-Roelse,J., Bouva, M., Winter-de Groot, Y. de, Schönbeck, Y., Gille, H., Gulmans, V.A.M., Verschoof-Puite, R., Dompeling, E., Schielen, P., and Verkerk, P.
- Subjects
Life ,Health ,CH - Child Health ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Healthy Living - Abstract
Workshop. Since May 1, 2011, newborn screening for Cystic Fibrosis (NBSCF) is part of the Dutch NBS program Objectives: To assess the validity of the four-step screening strategy when applied in a routine newborn screening program. Methods: NBSCF was carried out as a 4-step strategy (Immunotrypsinogen (IRT)/Pancreatitis-associated Protein (PAP)/DNA-analysis for 35 CFTR mutations/extended gene analysis (EGA) (Thorax 2012;67: 289). As safety net EGA-analysis was performed in samples with IRT ≥ 100 μg/L but no CF mutations. In 2013 the strategy was adapted: besides newborns with two mutations, either disease-causing or of unknown clinical relevance, also newborns with one disease-causing mutation were referred to a designated CF centre for further diagnosis. Data analysis was carried out as if the screening strategy was adapted during the whole period of data collection (May 1, 2011 to January 1, 2016). CF centres reported results of sweat tests and CF patients not identified by NBSCF in the NBS-registry. Carriers and newborns with CFSPID were considered false positives. Before data-analysis a cross checkwas performed comparing data in the NBS- and the Dutch CF patient-registry. Results: 819,518 newborns, 99.95% of all newborns, were screened for CF; in 8,131 IRTwas ≥60 μg/L, in 1,079 DNA-analysis followed PAP analysis; 121 had 2 CF mutations; EGA analysis was performed in 85 samples with 1 CF mutation, in 474 as safety net. 193 were screen-positive. CF was confirmed in 122, we found 27 CFSPID, 37 carriers. CF was excluded in 7. A false negative screening test was reported for 16 (4 with meconium ileus (MI)), in 8 caused by PAP values < cut-off levels. We calculated a specificity of 99.99%, PPV 63%, CF/CFSPID ratio of 5/1 and a sensitivity of 91% (without MI). Conclusion: PAP as additional marker in NBSCF appears to lead to an excellent true/false positive rate and the finding of a low number of carriers. Lower PAP cut-off from 1–7-2016 can improve sensitivity to standards of care.
- Published
- 2017
11. De neonatale hielprikscreening: monitor 2016 [The newborn blood spot screening in the Netherlands: monitor 2016]
- Author
-
Schönbeck, Y., Olthof, R., Ploeg, K. van der, and Verkerk, P.H.
- Subjects
Health ,Human Performances ,CH - Child Health ,Screening ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Newborn ,Blood spot ,Healthy Living ,Hielprikscreening - Abstract
De neonatale hielprikscreening (NHS) is in 1974 in Nederland ingevoerd en wordt gecoördineerd door het RIVM-Centrum voor Bevolkingsonderzoek (CvB). Het doel van de neonatale hielprikscreening is het vroegtijdig opsporen van een aantal ernstige aangeboren aandoeningen bij pasgeborenen. Kinderen met deze (zeldzame) aandoeningen hebben veel baat bij vroegtijdige interventies, zoals een geneesmiddel of een dieet. Hierdoor kan onherstelbare gezondheidsschade voorkomen of beperkt worden. De landelijke monitor met kerncijfers van de NHS wordt jaarlijks uitgevoerd door TNO in opdracht van het RIVM-CvB. Zo is te zien of de NHS-programmaonderdelen goed functioneren en of er misschien maatregelen genomen moeten worden om het programma beter te laten presteren.
- Published
- 2017
12. De neonatale hielprikscreening: monitor 2015
- Author
-
Schönbeck, Y. and Verkerk, P.H.
- Subjects
Health ,Human Performances ,CH - Child Health ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Healthy Living - Published
- 2016
13. Evaluatie van de neonatale hielprikscreening bij kinderen geboren in 2014
- Author
-
Rijpstra, A., Schönbeck, Y., and Verkerk, P.H.
- Subjects
Health ,CH - Child Health ,Healthy Living ,BSS - Behavioural and Societal Sciences ,Human - Published
- 2016
14. Procesmonitoring 2014: prenatale screening infectieziekten en erytrocytenimmunisatie (PSIE)
- Author
-
Ploeg, C.P.B. van der, Schönbeck, Y., Hirschberg, H., and Oomen, P.
- Subjects
Life ,Health ,CH - Child Health ,Prenatale screening ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Erytrocytenimmunisatie ,Healthy Living ,Infectieziekten - Abstract
Deze monitor beschrijft de belangrijkste resultaten van het bevolkingsonderzoek PSIE voor 2014 in vergelijking met voorgaande jaren [1-4]. De monitor omvat de gegevens van zwangeren met een eerste bloedonderzoek voor de PSIE in 2014. Dit eerste onderzoek wordt bij voorkeur voor de 13e week van de zwangerschap gedaan. Vervolgstappen later in de zwangerschap zijn deels in 2015 uitgevoerd.
- Published
- 2016
15. WS10.4 Performance of a four-step newborn screening strategy for CF in the Dutch screening program
- Author
-
Dankert-Roelse, J., primary, Bouva, M., additional, de Winter-de Groot, K., additional, Schönbeck, Y., additional, Gille, H., additional, Gulmans, V.A.M., additional, Verschoof-Puite, R., additional, Dompeling, E., additional, Schielen, P., additional, and Verkerk, P., additional
- Published
- 2017
- Full Text
- View/download PDF
16. Evaluatie van de neonatale hielprikscreening bij kinderen geboren in 2013
- Author
-
Rijpstra, A., Schönbeck, Y., and Verkerk, P.H.
- Subjects
Health ,CH - Child Health ,Healthy Living ,BSS - Behavioural and Societal Sciences ,Human - Published
- 2015
17. Multidisciplinaire richtlijn borstvoeding
- Author
-
Kamphuis, M. and Schönbeck , Y.
- Subjects
JGZ richtlijnen ,Life ,Health ,Ouders ,CH - Child Health ,Zuigelingen ,Borstvoeding ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Healthy Living - Abstract
De richtlijn Borstvoeding ondersteunt bij het informeren, stimuleren en adviseren van ouders van gezonde zuigelingen. Het uitgangspunt van deze richtlijn is het WHO-standpunt dat moedermelk de optimale voeding is voor zuigelingen en jonge kinderen.
- Published
- 2015
18. Procesmonitoring 2013: prenatale screening infectieziekten en erytrocytenimmunisatie (PSIE)
- Author
-
Ploeg, C.P.B. van der, Schönbeck, Y., and Hirschberg, H.
- Subjects
Life ,Health ,CH - Child Health ,Prenatale screening ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Erytrocytenimmunisatie ,Healthy Living ,Infectieziekten - Abstract
In deze monitor worden de belangrijkste resultaten beschreven van het bevolkingsonderzoek PSIE voor 2013 in vergelijking met voorgaande jaren [1,2,3]. De monitor omvat de gegevens van zwangeren met een bloedafnamedatum van het eerste bloedonderzoek voor de PSIE in 2013. Dit eerste onderzoek wordt bij voorkeur voor de 13e week van de zwangerschap gedaan. Vervolgstappen later in de zwangerschap zijn deels in 2014 uitgevoerd.
- Published
- 2015
19. Neonatale hielprikscreening: monitor 2014
- Author
-
Schönbeck, Y., Rijpstra, A., and Verkerk, P.H.
- Subjects
Health ,Human Performances ,CH - Child Health ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Healthy Living - Published
- 2015
20. Prenatale screening infectieziekten en erytrocytenimmunisatie (PSIE) : proces monitor 2013
- Author
-
Ploeg, C.P.B. van der, Schönbeck, Y., and Hirschberg, H.
- Subjects
Zwangerschapsscreening ,Life ,Health ,CH - Child Health ,Prenatale screening ,Erytocytenimmunisatie ,ELSS - Earth, Life and Social Sciences ,Healthy for Life ,Bevolkingsonderzoek ,Healthy Living - Abstract
Belangrijkste resultaten Prenatale Screening en erytrocytenimmunisatie over 2013. De Prenatale Screening Infectieziekten en Erytocytenimmuni-satie (PSIE) is een landelijk bevolkingsonderzoek waarbij een zwangere vrouw in het eerste verloskundige consult een bloedonderzoek aangeboden krijgt. Het bloed wordt gescreend op hepatitis B (hepB), syfilis, HIV, Rhesus (D)-antigeen (RhD), irregulaire erytrocyten antistoffen (IEA) en Rhesus (c)-antigeen (Rhc). Als uitslagen daartoe aanleiding geven, kunnen er binnen dit bevolkingsonderzoek verschillende acties in gang worden gezet. Het bevolkingsonderzoek heeft als doel hepatitis B- en HIV-dragerschap, congenitale syfilis en hemolytische ziekten van de foetus en/of de pasgeborene te voorkomen
- Published
- 2015
21. Aangeboren afwijkingen in Nederland 2001-2013 : Gebaseerd op de landelijke perinatale registraties
- Author
-
Schönbeck, Y., Hindori-Mohangoo, A.D., Masurel, N., and Pal-de Bruin, K.M. van der
- Subjects
Behavioural Changes ,Health ,CH - Child Health ,Afwijkingen ,Zuigelingen ,ELSS - Earth, Life and Social Sciences ,Neonatology - Abstract
In dit rapport is de prevalentie van aangeboren afwijkingen bij pasgeborenen in Nederland over de periode 2001-2013 in kaart gebracht. Het jaarlijkse monitoren van prevalenties van aangeboren afwijkingen is van belang om eventuele (plotselinge) dalingen of stijgingen (trends) te signaleren. In Nederland wordt de landelijke perinatale registratie van aangeboren afwijkingen beheerd door de Stichting Perinatale Registratie Nederland (PRN). In de Landelijke Verloskunde Registratie (LVR) worden door verloskundigen, huisartsen en gynaecologen gegevens over (losse) zwangerschappen, baringen en kraambedden vanaf 16 weken zwangerschap geregistreerd. In de Landelijke Neonatologie Registratie (LNR) worden door kinderartsen en neonatologen alle opnames, overnames en heropnames geregistreerd van pasgeborenen die zijn opgenomen binnen 28 dagen na geboorte. In alle deelregistraties worden ook aangeboren afwijkingen geregistreerd. Voor de registratiejaren 1995-2009 (2001-2009 worden in dit rapport gepresenteerd) werden de deelregistraties door de Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek (TNO) gekoppeld tot één landelijk LVR/LNR-bestand, waarbij de prevalentie van aangeboren afwijkingen werd berekend op basis van geëxtrapoleerde aantallen om rekening te houden met niet-registrerende zorgverleners. Sinds 2010 wordt de rapportage gebaseerd op een gekoppeld LVR/LNR-bestand van de Stichting PRN en worden prevalenties van aangeboren afwijkingen berekend op feitelijke aantallen aangeboren afwijkingen en pasgeborenen in het landelijk gekoppelde bestand. Door de overgang van de TNO-koppeling naar de bestanden van de Stichting PRN is een trendbreuk ontstaan. Derhalve zijn de statistische trendanalyses in dit rapport gebaseerd op de periode 2010-2013.
- Published
- 2015
22. ePS01.4 Improvement of the validity of the Dutch combined IRT/PAP/InnoLiPA/EGA newborn screening program for cystic fibrosis by re-evaluating mutation classification and optimizing cut-off values
- Author
-
Bouva, M.J., primary, Dankert-Roelse, J.E., additional, Verkerk, P.H., additional, Schönbeck, Y., additional, Verschoof-Puite, R.K., additional, Gulmans, V.A.M., additional, Lakeman, P., additional, de Winter-de Groot, K.M., additional, Gille, J.P., additional, Jakobs, B.S., additional, van der Stee, A., additional, and Schielen, P.C.J.I., additional
- Published
- 2016
- Full Text
- View/download PDF
23. Protocol for validation of the Global Scales for Early Development (GSED) for children under 3 years of age in seven countries.
- Author
-
Cavallera V, Lancaster G, Gladstone M, Black MM, McCray G, Nizar A, Ahmed S, Dutta A, Anago RKE, Brentani A, Jiang F, Schönbeck Y, McCoy DC, Kariger P, Weber AM, Raikes A, Waldman M, van Buuren S, Kaur R, Pérez Maillard M, Nisar MI, Khanam R, Sazawal S, Zongo A, Pacifico Mercadante M, Zhang Y, Roy AD, Hepworth K, Fink G, Rubio-Codina M, Tofail F, Eekhout I, Seiden J, Norton R, Baqui AH, Khalfan Ali J, Zhao J, Holzinger A, Detmar S, Kembou SN, Begum F, Mohammed Ali S, Jehan F, Dua T, and Janus M
- Subjects
- Humans, Child, Child, Preschool, Reproducibility of Results, Cross-Sectional Studies, Surveys and Questionnaires, Psychometrics methods, Caregivers, Language
- Abstract
Introduction: Children's early development is affected by caregiving experiences, with lifelong health and well-being implications. Governments and civil societies need population-based measures to monitor children's early development and ensure that children receive the care needed to thrive. To this end, the WHO developed the Global Scales for Early Development (GSED) to measure children's early development up to 3 years of age. The GSED includes three measures for population and programmatic level measurement: (1) short form (SF) (caregiver report), (2) long form (LF) (direct administration) and (3) psychosocial form (PF) (caregiver report). The primary aim of this protocol is to validate the GSED SF and LF. Secondary aims are to create preliminary reference scores for the GSED SF and LF, validate an adaptive testing algorithm and assess the feasibility and preliminary validity of the GSED PF., Methods and Analysis: We will conduct the validation in seven countries (Bangladesh, Brazil, Côte d'Ivoire, Pakistan, The Netherlands, People's Republic of China, United Republic of Tanzania), varying in geography, language, culture and income through a 1-year prospective design, combining cross-sectional and longitudinal methods with 1248 children per site, stratified by age and sex. The GSED generates an innovative common metric (Developmental Score: D-score) using the Rasch model and a Development for Age Z-score (DAZ). We will evaluate six psychometric properties of the GSED SF and LF: concurrent validity, predictive validity at 6 months, convergent and discriminant validity, and test-retest and inter-rater reliability. We will evaluate measurement invariance by comparing differential item functioning and differential test functioning across sites., Ethics and Dissemination: This study has received ethical approval from the WHO (protocol GSED validation 004583 20.04.2020) and approval in each site. Study results will be disseminated through webinars and publications from WHO, international organisations, academic journals and conference proceedings., Registration Details: Open Science Framework https://osf.io/ on 19 November 2021 (DOI 10.17605/OSF.IO/KX5T7; identifier: osf-registrations-kx5t7-v1)., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
24. The creation of the Global Scales for Early Development (GSED) for children aged 0-3 years: combining subject matter expert judgements with big data.
- Author
-
McCray G, McCoy D, Kariger P, Janus M, Black MM, Chang SM, Tofail F, Eekhout I, Waldman M, van Buuren S, Khanam R, Sazawal S, Nizar A, Schönbeck Y, Zongo A, Brentani A, Zhang Y, Dua T, Cavallera V, Raikes A, Weber AM, Bromley K, Baqui A, Dutta A, Nisar I, Detmar SB, Anago R, Mercadante P, Jiang F, Kaur R, Hepworth K, Rubio-Codina M, Kembou SN, Ahmed S, Lancaster GA, and Gladstone M
- Subjects
- Humans, Child, Child, Preschool, Surveys and Questionnaires, Child Development, Psychometrics, Judgment, Big Data
- Abstract
Introduction: With the ratification of the Sustainable Development Goals, there is an increased emphasis on early childhood development (ECD) and well-being. The WHO led Global Scales for Early Development (GSED) project aims to provide population and programmatic level measures of ECD for 0-3 years that are valid, reliable and have psychometrically stable performance across geographical, cultural and language contexts. This paper reports on the creation of two measures: (1) the GSED Short Form (GSED-SF)-a caregiver reported measure for population-evaluation-self-administered with no training required and (2) the GSED Long Form (GSED-LF)-a directly administered/observed measure for programmatic evaluation-administered by a trained professional., Methods: We selected 807 psychometrically best-performing items using a Rasch measurement model from an ECD measurement databank which comprised 66 075 children assessed on 2211 items from 18 ECD measures in 32 countries. From 766 of these items, in-depth subject matter expert judgements were gathered to inform final item selection. Specifically collected were data on (1) conceptual matches between pairs of items originating from different measures, (2) developmental domain(s) measured by each item and (3) perceptions of feasibility of administration of each item in diverse contexts. Prototypes were finalised through a combination of psychometric performance evaluation and expert consensus to optimally identify items., Results: We created the GSED-SF (139 items) and GSED-LF (157 items) for tablet-based and paper-based assessments, with an optimal set of items that fit the Rasch model, met subject matter expert criteria, avoided conceptual overlap, covered multiple domains of child development and were feasible to implement across diverse settings., Conclusions: State-of-the-art quantitative and qualitative procedures were used to select of theoretically relevant and globally feasible items representing child development for children aged 0-3 years. GSED-SF and GSED-LF will be piloted and validated in children across diverse cultural, demographic, social and language contexts for global use., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
25. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.
- Author
-
van der Linde AAA, Schönbeck Y, van der Kamp HJ, van den Akker ELT, van Albada ME, Boelen A, Finken MJJ, Hannema SE, Hoorweg-Nijman G, Odink RJ, Schielen PCJI, Straetemans S, van Trotsenburg PS, Claahsen-van der Grinten HL, and Verkerk PH
- Subjects
- Adrenal Hyperplasia, Congenital diagnosis, Adrenal Hyperplasia, Congenital pathology, Female, Humans, Incidence, Infant, Newborn, Male, Netherlands epidemiology, Retrospective Studies, Sensitivity and Specificity, Adrenal Hyperplasia, Congenital epidemiology, Neonatal Screening standards
- Abstract
Background: In 2002, a nationwide screening for congenital adrenal hyperplasia (CAH) was introduced in the Netherlands. The aim of our study is to evaluate the validity of the neonatal screening for CAH and to assess how many newborns with salt-wasting (SW) CAH have already been clinically diagnosed before the screening result was known., Methods: Retrospective, descriptive study. The following data of patients with positive screening results since implementation of the screening programme were collected (1 January 2002 up until 31 December 2013): gestational age, sex, diagnosis, clinical presentation and contribution of screening to the diagnosis., Results: In the evaluated period, 2 235 931 newborns were screened. 479 children had an abnormal screening result, 133 children were diagnosed with CAH (114 SW, 14 simple virilizing (SV)), five non-classic CAH. During this period, no patients with SW CAH were missed by neonatal screening (sensitivity was 100%). After exclusion of 17 cases with missing information on diagnosis, specificity was 99.98% and positive predictive value was 24.7%. Most false positives (30%) were attributable to prematurity. Of patients with SW CAH, 68% (71/104) patients were detected by neonatal screening and 33 (33/104) were clinically diagnosed. Of girls with SW CAH, 38% (14/37) were detected by neonatal screening and 62% (23/37) were clinically diagnosed., Conclusion: The Dutch neonatal screening has an excellent sensitivity and high specificity. Both boys and girls can benefit from neonatal screening., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
26. Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands.
- Author
-
Dankert-Roelse JE, Bouva MJ, Jakobs BS, Janssens HM, de Winter-de Groot KM, Schönbeck Y, Gille JJP, Gulmans VAM, Verschoof-Puite RK, Schielen PCJI, and Verkerk PH
- Subjects
- Biomarkers blood, Cystic Fibrosis blood, Cystic Fibrosis epidemiology, Cystic Fibrosis Transmembrane Conductance Regulator analysis, DNA Mutational Analysis, Female, Humans, Infant, Newborn, Male, Netherlands epidemiology, ROC Curve, Reproducibility of Results, Cystic Fibrosis diagnosis, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Genetic Carrier Screening methods, Guidelines as Topic, Mutation, Neonatal Screening standards, Registries
- Abstract
Background: Newborn screening for cystic fibrosis (NBSCF) was introduced in the Dutch NBS program in 2011 with a novel strategy., Methods: Dutch NBSCF consisted of four steps: immuno-reactive trypsin (IRT), Pancreatitis-associated Protein (PAP), DNA analysis by Inno-LiPa (35 mutations), extended gene analysis (EGA) as fourth step and as safety net. Only samples with two CFTR-variants were considered screen-positive, but samples with one disease-causing variant were considered also screen-positive from April 2013. The first 5 years of NBSCF were evaluated during a follow-up ranging from 2 to 6.8 years for sensitivity, specificity, positive predictive value (PPV), ratio of CF/Cystic Fibrosis Screen Positive infants with an Inconclusive Diagnosis (CFSPID) and median age at diagnosis, and were compared to other novel strategies for NBSCF and European Cystic Fibrosis Society (ECFS) Best Practice Standards of Care., Results: NBSCF achieved a sensitivity of 90% (95% CI 82%-94%), specificity of 99.991% (95% CI 99.989%-99.993%), PPV of 63% (95% CI 55%-69%), CF/CFSPID ratio of 4/1, and median age at diagnosis of 22 days, if samples with two variants as well as samples with one disease-causing variant were considered screen-positive., Conclusion: The program achieved the goal to minimize the number of false positives and showed a favourable performance but sensitivity and CF/CFSPID ratio did not meet criteria of EFCS Best Standards of Care. Changed cut-off values for PAP and IRT and classification of R117H-7T/9T to non-pathogenic may improve sensitivity to ≥95% and CF/CFSPID ratio to 10/1. PPV is estimated to be around 60%., (Copyright © 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
27. Call for early prevention: prevalence rates of overweight among Turkish and Moroccan children in The Netherlands.
- Author
-
van Dommelen P, Schönbeck Y, HiraSing RA, and van Buuren S
- Subjects
- Adolescent, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Life Style, Male, Morocco ethnology, Netherlands epidemiology, Overweight prevention & control, Pediatric Obesity epidemiology, Prevalence, Surveys and Questionnaires, Turkey ethnology, Overweight epidemiology, Pediatric Obesity prevention & control
- Abstract
Background: Monitoring overweight in risk groups is necessary. Our aim is to assess the trend in overweight and obesity in Turkish and Moroccan children in the Netherlands since 1997 and to monitor the levels of lifestyle-related behaviours in 2009., Methods: We selected cross-sectional data of Turkish and Moroccan children aged 2-18 years from two national Growth Studies performed in 1997 and 2009 in the Netherlands. Lifestyle-related behaviours were obtained in the 2009 study by questionnaire., Results: In 2009, 31.9% of Turkish and 26.6% of Moroccan children had overweight, whereas this was, respectively, 26.7% and 19.6% in 1997. Already at 2 years, 21.1% in Turkish and 22.7% in Moroccan children had overweight in 2009. The prevalence of obesity was above 4% from 3 years onwards. High (i.e. ≥ 25%) prevalence rates of unhealthy lifestyle-related behaviours were found for not having breakfast (26-49%) among Turkish and Moroccan adolescent (i.e. 15-18 years) girls, consuming no fruit (29-45%) and watching TV/PC ≥ 2 h (35-72%) among all Turkish and Moroccan adolescents, no walking/cycling to school/day care among preschool children (2-4 years) (28-56%) and adolescents (34-94%), drinking ≥ 2 glasses of sweet beverages (44-74%) and being <1 h physically active (29-65%) among all children., Conclusion: An upward trend of overweight and obesity occurred in Turkish and Moroccan children. Already at 2 years of age, one out of five Turkish and Moroccan children had overweight, which calls for early prevention with attention to specific lifestyle-related behaviours., (© The Author 2015. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
28. Trend in height of Turkish and Moroccan children living in the Netherlands.
- Author
-
Schönbeck Y, van Dommelen P, HiraSing RA, and van Buuren S
- Subjects
- Adolescent, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Morocco, Netherlands epidemiology, Reference Values, Turkey, World Health Organization, Body Height physiology
- Abstract
Objectives: To study trends in height of Turkish and Moroccan immigrant children living in The Netherlands, to investigate the association between height and background characteristics in these children, and to calculate height-for-age-references data for these groups., Design: Nationwide cross-sectional data collection from children aged 0 to 18 years by trained professionals in 1997 and 2009. The study population consisted of 2,822 Turkish 2,779 Moroccan, and 13,705 Dutch origin children in 1997 and 2,548 Turkish, 2,594 Moroccan, and 11,255 Dutch origin children in 2009., Main Outcome Measures: Mean height in cm, and mean height standard deviation scores., Results: In 2009, mean height at the age of 18 y was similar for Turkish and Moroccan children: 177 cm for boys and 163 cm for girls, which was 2 to 3 cm taller than in 1997. Still, Turkish and Moroccan adolescents were 5.5 cm (boys) to 7 cm (girls) shorter than their Dutch peers. No significant differences were found in mean height standard deviation scores across the educational level of the parents, geographical region, primary language spoken at home, and immigrant generation., Conclusions: While the secular height increase in Dutch children came to a halt, the trend in Turkish and Moroccan children living in The Netherlands continued. However, large differences in height between Turkish and Moroccan children and Dutch children remain. We found no association with the background characteristics. We recommend the use of the new growth charts for children of Turkish and Moroccan origin who have a height-for-age below -2SD on the growth chart for Dutch children.
- Published
- 2015
- Full Text
- View/download PDF
29. Thinness in the era of obesity: trends in children and adolescents in The Netherlands since 1980.
- Author
-
Schönbeck Y, van Dommelen P, HiraSing RA, and van Buuren S
- Subjects
- Adolescent, Age Factors, Body Mass Index, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Male, Netherlands epidemiology, Prevalence, Thinness epidemiology
- Abstract
Background: Although children both at the upper and lower tail of the body mass index (BMI) distribution are at greater health risk, relatively little is known about the development of thinness prevalence rates in developed countries over time. We studied trends in childhood thinness and assessed changes in the BMI distribution since the onset of the obesity epidemic., Methods: Growth data from 54 814 children aged 2-18 years of Dutch, Turkish and Moroccan origin living in The Netherlands were used. Anthropometric measurements were performed during nationwide cross-sectional growth studies in 1980 (only Dutch), 1997 and 2009. Prevalence rates of thinness grades I, II and III were calculated according to international cut-offs. BMI distributions for 1980, 1997 and 2009 were compared., Results: Since 1980, thinness (all grades combined) reduced significantly from 14.0% to 9.8% in children of Dutch origin, but the proportion of extremely thin children (grade III) remained constant. Thinness in children of Moroccan origin decreased significantly from 8.8% to 6.2% between 1997 and 2009. No significant difference was observed in children of Turkish origin (5.4% in 1997 vs. 5.7% in 2009). Thinness occurred most often in children aged 2-5 years. There were no differences between boys and girls. The BMI distribution widened since 1980, mainly due to an upward shift of the upper centiles., Conclusion: Since the onset of the obesity epidemic, prevalence rates of thinness decreased. However, we found a small but persistent group of extremely thin children. More research is needed to gain insight into their health status., (© The Author 2014. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.